Atrium Therapeutics, Inc.
RNA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002093101
No open-market purchases or sales by Atrium Therapeutics, Inc. insiders were filed in the last 90 days; 154 institutions reported holding it in 13F filings for Q2 2026, worth $192.8M in total; no superinvestor holds it.
SEC filings
10-K, 10-Q, 8-K, 20-F and 40-F reports Atrium Therapeutics, Inc. filed with the SEC, newest first.
Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.
| Filed | Form | 8-K items | Period | Document | Filing index |
|---|---|---|---|---|---|
| Nov 12, 2026 | 10-Q | – | Sep 30, 2026 | SEC | Index |
| Nov 12, 2026 | 8-K | 2.029.01 | Nov 12, 2026 | SEC | Index |
| Nov 2, 2026 | 8-K | 7.018.019.01 | Nov 2, 2026 | SEC | Index |
| Oct 27, 2026 | 8-K | 8.019.01 | Oct 27, 2026 | SEC | Index |
| Oct 9, 2026 | 8-K/A | 8.01 | Oct 7, 2026 | SEC | Index |
| Oct 8, 2026 | 8-K | 1.013.028.019.01 | Oct 7, 2026 | SEC | Index |
| Aug 13, 2026 | 10-Q | – | Jun 30, 2026 | SEC | Index |
| Aug 13, 2026 | 8-K | 2.029.01 | Aug 13, 2026 | SEC | Index |
| Jul 14, 2026 | 8-K | 8.019.01 | Jul 14, 2026 | SEC | Index |
| May 14, 2026 | 10-Q | – | Mar 31, 2026 | SEC | Index |
| May 14, 2026 | 8-K | 2.029.01 | May 14, 2026 | SEC | Index |
| Feb 27, 2026 | 8-K | 1.015.015.029.01 | Feb 26, 2026 | SEC | Index |
| Feb 26, 2026 | 8-K | 7.019.01 | Feb 26, 2026 | SEC | Index |